Bath & Body Works (NYSE:BBWI) Updates FY 2025 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 3.250-3.600 for the period, compared to the consensus earnings per share estimate of 3.650. The company issued revenue guidance of $7.4 billion-$7.5 billion, compared to the consensus revenue estimate of $7.5 billion. Bath & Body Works also updated its Q1 2025 guidance to 0.360-0.430 EPS.

Wall Street Analysts Forecast Growth

BBWI has been the subject of a number of recent analyst reports. TD Cowen upped their target price on Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. Raymond James reaffirmed an “outperform” rating and set a $46.00 price objective (up from $42.00) on shares of Bath & Body Works in a report on Tuesday. JPMorgan Chase & Co. raised shares of Bath & Body Works from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $41.00 to $47.00 in a research report on Tuesday, February 18th. Wells Fargo & Company upgraded shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $42.00 to $48.00 in a report on Friday, January 10th. Finally, Citigroup upgraded Bath & Body Works from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $40.00 to $48.00 in a research note on Friday. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, Bath & Body Works has a consensus rating of “Moderate Buy” and a consensus price target of $45.38.

Bath & Body Works Trading Up 0.9 %

Shares of BBWI stock traded up $0.31 on Friday, hitting $36.17. 3,136,003 shares of the stock were exchanged, compared to its average volume of 3,663,079. The business has a 50-day moving average of $37.76 and a 200 day moving average of $34.08. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The firm has a market capitalization of $7.83 billion, a P/E ratio of 8.82, a price-to-earnings-growth ratio of 0.92 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to analysts’ expectations of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, research analysts forecast that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.21%. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.

Bath & Body Works declared that its Board of Directors has authorized a stock buyback plan on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to buy up to 6.4% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.